Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Orchard Therapeutics plc (ORTX)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Jun-05-23Mar-31-23Mar-05-23Dec-31-22Dec-05-22Sep-30-22Jun-30-22
   10-Q8-K10-Q8-K10-K8-K10-Q10-Q
Net income  -85.2 -123.8 -150.7 -179.1-168.0
Depreciation and amortization   [+]2.7 2.7 2.7 2.72.7
Change in working capital      34.3   
Other operating activities  -39.2 0.9 37.6 19.49.8
Cash from operations  -87.4 -85.9 -76.0 -97.3-95.8
   
Capital expenditures  5.4 6.6 6.5 6.43.0
Purchases of short-term investments  175.9 121.4 112.3 92.8147.8
Other cash from investing  -171.6 -72.0 -28.2 7.7-104.0
Cash from investing  9.8 56.1 90.6 106.946.8
   
Option exercises  0.3 0.3 0.2 0.70.6
Other cash from financing  61.9 31.1 -0.5 0.95.0
Cash from financing  61.6 30.8 -0.7 0.34.3
   
Free cash flow  -81.9 -79.3 -69.5 -90.9-92.8
        Per share (diluted)  ($0.56) ($0.60) ($0.54) ($0.72)($0.73)
   
Cash paid for interest  3.1 2.9 2.6 2.42.3

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy